Austria's Pharmig looks to "sharpen" image
Austria's drug industry association, Pharmig, has confirmed that its president, Hubert Dressler, is to remain in his post at least until April 2009, despite local media speculation about a possible change at the top. Mr Dressler is the operational managing director of the local subsidiary of French drug major Sanofi-Aventis. The Pharmig's secretary general, Jan Oliver Huber, stressed that "the executive committee unanimously confirmed [Mr Dressler] remaining in office at the last closed conference."
The Pharmig meeting also decided to expand the group's executive committee. The newcomers are Kurt Herpel (MSD), Beat Kasper (Roche) and Andreas Kronberger (Baxter). Mr Huber added that the 10-member executive team will "sharpen" the Pharmig's public profile.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze